Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
1994
|
| gptkbp:headquarters_location |
gptkb:Shanghai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fosun Pharma (China)
|
| gptkbp:industry |
healthcare
pharmaceuticals |
| gptkbp:keyPerson |
gptkb:Chen_Qiyu
gptkb:Wu_Yifang |
| gptkbp:notableProduct |
gptkb:COVID-19_mRNA_vaccine_(Comirnaty)
|
| gptkbp:numberOfEmployees |
over 20,000
|
| gptkbp:parentCompany |
gptkb:Fosun_International
|
| gptkbp:partner |
gptkb:BioNTech
|
| gptkbp:products |
medical devices
pharmaceutical drugs diagnostic products |
| gptkbp:stockExchange |
gptkb:Hong_Kong_Stock_Exchange
gptkb:Shanghai_Stock_Exchange |
| gptkbp:website |
https://www.fosunpharma.com/en/
|
| gptkbp:bfsParent |
gptkb:Pfizer-BioNTech
|
| gptkbp:bfsLayer |
5
|